Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.

about

Strengths and weaknesses of 'real-world' studies involving non-vitamin K antagonist oral anticoagulants.

Item

http://www.wikidata.org/entity/Q55176626

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@en

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@nl

type

Item

label

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@en

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@nl

prefLabel

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@en

Strengths and weaknesses of 'r ...... ntagonist oral anticoagulants.

@nl

P1476

Strengths and weaknesses of 'r ...... antagonist oral anticoagulants

@en

P2093

A John Camm

http://www.w3.org/2001/XMLSchema#string

P2860

Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity

Dabigatran versus warfarin in patients with atrial fibrillation

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

Apixaban versus warfarin in patients with atrial fibrillation

Edoxaban versus warfarin in patients with atrial fibrillation

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events--European Registry in Atrial Fibrillation (PREFER in AF)

Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.

Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.

Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study

The value of pragmatic and observational studies in health care and public health.

P304

e000788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/OPENHRT-2018-000788

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

K A Fox

P577

2018-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29713485

http://www.w3.org/2001/XMLSchema#string

P921

vitamin K

anticoagulation

P932

5922572

http://www.w3.org/2001/XMLSchema#string